LAQUITA DAWKINS: Open Payments
NPI 1699166132 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,424 in 41 payments from 7 companies in 2025. Trend: 2023 $520 · 2024 $443 · 2025 $1,424
Food & beverage: $1,203Education: $221
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 14 | $570 |
| E.R. Squibb & Sons, L.L.C. | 2 | $240 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $220 |
| ABBVIE INC. | 15 | $208 |
| Axsome Therapeutics, Inc. | 2 | $146 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
Products named: COBENFY, CAPLYTA, VRAYLAR, UZEDY, AUSTEDO XR, Auvelity, Qelbree, FANAPT.
Industry payments across NY — which companies pay providers there.
